[{"data":1,"prerenderedAt":249},["ShallowReactive",2],{"drug-cefpodoxime":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":43,"contraindications":128,"warnings":138,"renal":139,"monitoring":148,"interactions":149,"review":150,"examples":153,"atc":176,"iran":178,"links":190,"populations":208,"usApproval":244},"cefpodoxime",1,{"fa":7,"en":8},"سفپودوکسیم","Cefpodoxime","anti-infectives",{"fa":11,"en":12},"سفالوسپورین نسل سوم","Third-generation cephalosporin",[14],{"name":15,"market":16},"Vantin","US",[4,7,18,19],"اوروپودوکس","orelox",[21,35],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"susp-50","suspension","oral","50 mg \u002F 5 mL",{"amount":27,"unit":28,"perVolumeMl":29},50,"mg",5,[16],[32],{"source":33,"section":34},"fda-cefpodoxime","How Supplied",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"susp-100","100 mg \u002F 5 mL",{"amount":39,"unit":28,"perVolumeMl":29},100,[16],[42],{"source":33,"section":34},[44,68,85,101,115],{"id":45,"disease":46,"label":47,"population":50,"type":57,"unit":28,"dose":58,"refs":59,"limits":62,"durationDays":67},"aom","acute-otitis-media",{"fa":48,"en":49},"اوتیت میانی حاد — کودک ۲ ماه تا ۱۲ سال: ۵ mg\u002Fkg هر ۱۲ ساعت، ۵ روز","Acute otitis media — 2 months–12 y: 5 mg\u002Fkg every 12 h, 5 days",{"minAge":51,"maxAge":54},{"value":52,"unit":53},2,"month",{"value":55,"unit":56},12,"year","weightBased",{"perKgPerDose":29,"intervalHours":55},[60],{"source":33,"section":61},"Dosage and Administration",{"maxPerDose":63,"maxPerDay":64,"refs":65},200,400,[66],{"source":33,"section":61},{"min":29,"max":29},{"id":69,"disease":70,"label":71,"population":74,"type":57,"unit":28,"dose":77,"refs":78,"limits":80,"durationDays":83},"pharyngitis","streptococcal-pharyngitis",{"fa":72,"en":73},"فارنژیت — کودک: ۵ mg\u002Fkg هر ۱۲ ساعت (حداکثر ۱۰۰ mg در دوز)","Pharyngitis — child: 5 mg\u002Fkg every 12 h (max 100 mg\u002Fdose)",{"minAge":75,"maxAge":76},{"value":52,"unit":53},{"value":55,"unit":56},{"perKgPerDose":29,"intervalHours":55},[79],{"source":33,"section":61},{"maxPerDose":39,"maxPerDay":63,"refs":81},[82],{"source":33,"section":61},{"min":29,"max":84},10,{"id":86,"disease":87,"label":88,"population":91,"type":57,"unit":28,"dose":94,"refs":95,"limits":97,"durationDays":100},"sinusitis","acute-bacterial-sinusitis",{"fa":89,"en":90},"سینوزیت — کودک: ۵ mg\u002Fkg هر ۱۲ ساعت، ۱۰ روز","Sinusitis — child: 5 mg\u002Fkg every 12 h, 10 days",{"minAge":92,"maxAge":93},{"value":52,"unit":53},{"value":55,"unit":56},{"perKgPerDose":29,"intervalHours":55},[96],{"source":33,"section":61},{"maxPerDose":63,"maxPerDay":64,"refs":98},[99],{"source":33,"section":61},{"min":84,"max":84},{"id":102,"disease":103,"label":104,"population":107,"type":109,"unit":28,"dose":110,"refs":111,"durationDays":113},"adult-cap","community-acquired-pneumonia",{"fa":105,"en":106},"پنومونی اکتسابی — ۱۲ سال به بالا: ۲۰۰ mg هر ۱۲ ساعت، ۱۴ روز","CAP — ≥12 y: 200 mg every 12 h, 14 days",{"minAge":108},{"value":55,"unit":56},"fixed",{"perDose":63,"dosesPerDay":52},[112],{"source":33,"section":61},{"min":114,"max":114},14,{"id":116,"disease":117,"label":118,"population":121,"type":109,"unit":28,"dose":123,"refs":124,"durationDays":126},"adult-uti","urinary-tract-infection",{"fa":119,"en":120},"عفونت ادراری ساده — ۱۲ سال به بالا: ۱۰۰ mg هر ۱۲ ساعت، ۷ روز","Uncomplicated UTI — ≥12 y: 100 mg every 12 h, 7 days",{"minAge":122},{"value":55,"unit":56},{"perDose":39,"dosesPerDay":52},[125],{"source":33,"section":61},{"min":127,"max":127},7,[129],{"id":130,"severity":131,"text":132,"refs":135},"ci","block",{"fa":133,"en":134},"حساسیت به سفالوسپورین‌ها.","Allergy to cephalosporins.",[136],{"source":33,"section":137},"Contraindications",[],[140],{"egfrBelow":141,"severity":142,"text":143,"refs":146},30,"warn",{"fa":144,"en":145},"کلیرانس زیر ۳۰: فاصله دوز ۲۴ ساعت.","CrCl \u003C30: dose every 24 h.",[147],{"source":33,"section":61},[],[],{"status":151,"reviewer":152,"date":152},"unverified",null,[154,158,163,168,172],{"regimen":45,"formulation":36,"input":155,"expect":156},{"ageYears":5,"weightKg":84},{"perDose":27,"mlPerDose":157},2.5,{"regimen":69,"formulation":36,"input":159,"expect":162},{"ageYears":160,"weightKg":161},8,25,{"perDose":39,"mlPerDose":29},{"regimen":86,"formulation":36,"input":164,"expect":167},{"ageYears":165,"weightKg":166},6,20,{"perDose":39},{"regimen":102,"formulation":36,"input":169,"expect":171},{"ageYears":141,"weightKg":170},70,{"perDose":63,"mlPerDose":84},{"regimen":116,"formulation":36,"input":173,"expect":175},{"ageYears":141,"weightKg":174},60,{"perDose":39,"mlPerDose":29},[177],"J01DD13",{"status":179,"forms":180,"refs":185},"registered",[181],{"code":182,"en":183,"fa":184},"08913","CEFPODOXIM 100MG TAB","قرص سفپودوکسیم ۱۰۰ میلی‌گرم",[186],{"source":187,"section":188,"url":189},"darooyab-generic","G-342\u002FCefpodoxime-Proxetil","https:\u002F\u002Fwww.darooyab.ir\u002FG-342\u002FCefpodoxime-Proxetil",[191,195,199,202,205],{"kind":192,"url":193,"label":194},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=065409","ANDA065409",{"kind":196,"url":197,"label":198},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=edf589b2-f796-4522-a5e6-2bd0a833922f","FDA Cefpodoxime susp.",{"kind":200,"url":201,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa698024.html",{"kind":203,"url":204,"label":177},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=J01DD13",{"kind":206,"url":189,"label":207},"darooyab","Cefpodoxime-Proxetil",{"pregnancy":209,"lactation":218,"pediatric":227,"geriatric":235},{"level":210,"text":211,"quote":214,"refs":215},"caution",{"fa":212,"en":213},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor embryocidal when administered to rats during organogenesis at doses up to 100 mg\u002Fkg\u002Fday (2 times the human dose based on mg\u002Fm 2 ) or to rabbits at doses up to 30 mg\u002Fkg\u002Fday (1 to 2 times the human dose based on mg\u002Fm 2 ).",[216],{"source":33,"section":217},"Pregnancy - Teratogenic Effects:",{"level":219,"text":220,"quote":223,"refs":224},"avoid",{"fa":221,"en":222},"برچسب: شیردهی توصیه نمی‌شود یا باید بین دارو و شیردهی یکی انتخاب شود.","Label: breastfeeding not recommended, or choose between the drug and breastfeeding.","Because of the potential for serious reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.",[225],{"source":33,"section":226},"Nursing Mothers:",{"level":210,"text":228,"quote":231,"refs":232},{"fa":229,"en":230},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and efficacy in infants less than 2 months of age have not been established.",[233],{"source":33,"section":234},"Pediatric Use:",{"level":236,"text":237,"quote":240,"refs":241},"ok",{"fa":238,"en":239},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in effectiveness or safety were observed between the elderly and younger patients.",[242],{"source":33,"section":243},"Geriatric Use:",{"kind":245,"refs":246,"id":194},"ANDA",[247],{"source":33,"section":248},"SPL approval \u002F marketing category",1792092026483]